| 1 |
窦科峰. 异种移植学[M]. 北京：人民军医出版社，2014.
|
| 2 |
Längin M, Mayr T, Reichart B, et al. Consistent success in life-supporting porcine cardiac xenotransplantation[J]. Nature, 2018, 564(7736): 430-433.
|
| 3 |
Shah AM, Han JJ. First successful porcine to human heart transplantation performed in the United States[J]. Artif Organs, 2022, 46(4): 543-545.
|
| 4 |
Higginbotham L, Mathews D, Breeden CA, et al. Pre‐transplant antibody screening and anti‐CD154 costimulation blockade promote long‐term xenograft survival in a pig‐to‐primate kidney transplant model[J]. Xenotransplantation, 2015, 22(3): 221-230.
|
| 5 |
Iwase H, Liu H, Wijkstrom M, et al. Pig kidney graft survival in a baboon for 136: longest life‐supporting organ graft survival to date[J]. Xenotransplantation, 2015, 22(4): 302-309.
|
| 6 |
Iwase H, Hara H, Ezzelarab M, et al. Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts[J]. Xenotransplantation, 2017, 24(2): e12293.
|
| 7 |
Adams AB, Kim SC, Martens GR, et al. Xenoantigen deletion and chemical immunosuppression can prolong renal xenograft survival[J]. Ann Surg, 2018, 268(4): 564-573.
|
| 8 |
于佳庆，方一晽，方铭慧，等. 猪肾脏异种移植的研究进展[J]. 吉林大学学报(医学版), 2021, 47(3): 788-795.
|
| 9 |
Pierson RN 3rd, Burdorf L, Madsen JC, et al. Pig-to-human heart transplantation: Who goes first？[J]. Am J Transplant, 2020, 20(10): 2669-2674.
|
| 10 |
McGregor CGA, Byrne GW. Porcine to human heart transplantation: is clinical application now appropriate？[J]. J Immunol Res, 2017, 2017: 2534653.
|
| 11 |
Cooper D, Ezzelarab M, Iwase H, et al. Perspectives on the optimal genetically engineered pig in 2018 for initial clinical trials of kidney or heart xenotransplantation[J]. Transplantation, 2018, 102(12): 1974-1982.
|
| 12 |
Byrne G, Ahmad-Villiers S, Du Z, et al. B4GALNT2 and xenotransplantation: a newly appreciated xenogeneic antigen[J]. Xenotransplantation, 2018, 25(5): e12394.
|
| 13 |
Feng H, Li T, Du J, et al. Both natural and induced anti-sda antibodies play important roles in GTKO pig-to-rhesus monkey xenotransplantation[J]. Front Immunol, 2022, 13: 849711.
|
| 14 |
李丹妮，赵艳双，王轶，等. 异种移植新进展：从实验到临床[J]. 中国普外基础与临床杂志，2022, 29(6): 705-710.
|
| 15 |
Hammer SE, Ho CS, Ando A, et al. Importance of the major histocompatibility complex (swine leukocyte antigen) in swine health and biomedical research[J]. Annu Rev Anim Biosci, 2020, 8: 171-198.
|
| 16 |
Elisseeff J, Badylak SF, Boeke JD. Immune and genome engineering as the future of transplantable tissue[J]. N Engl J Med, 2021, 385(26): 2451-2462.
|
| 17 |
Fischer K, Rieblinger B, Hein R, et al. Viable pigs after simultaneous inactivation of porcine MHC class I and three xenoreactive antigen genes GGTA1, CMAH and B4GALNT2[J]. Xenotransplantation, 2020, 27(1): e12560.
|
| 18 |
Cooper DKC, Hara H, Iwase H, et al. Clinical pig kidney xenotransplantation: How close are we？[J]. J Am Soc Nephrol, 2020, 31(1)：12-21.
|
| 19 |
Pan D, Liu T, Lei T, et al. Progress in multiple genetically modified minipigs for xenotransplantation in China[J]. Xenotransplantation, 2019, 26(1): e12492.
|
| 20 |
Chan JL, Singh AK, Corcoran PC, et al. Encouraging experience using multi-transgenic xenografts in a pig-to-baboon cardiac xenotransplantation model[J]. Xenotransplantation, 2017, 24(6): e12330.
|
| 21 |
Guell M, Niu D, Kan Y, et al. PERV inactivation is necessary to guarantee absence of pig-to-patient PERVs transmission in xenotransplantation[J]. Xenotransplantation, 2017, 24(6): e12366.
|
| 22 |
Salvaris EJ, Moran CJ, Roussel JC, et al. Pig endothelial protein C receptor is functionally compatible with the human protein C pathway[J]. Xenotransplantation, 2020, 27(2): e12557.
|
| 23 |
Adams DH, Chen RH, Kadner A, et al. Technique for heterotopic pig heart xenotransplantation in primates[J]. Ann Thorac Surg, 1999, 68(1): 265-268.
|
| 24 |
Platt J L. Acute vascular rejection[J]. Transplant Proc, 2000, 32(5): 839-840.
|
| 25 |
Shimizu A, Yamada K, Yamamoto S, et al. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts[J]. J Am Soc Nephrol, 2005, 16(9): 2732-2745.
|
| 26 |
Chen G, Qian H, Starzl T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys[J]. Nat Med, 2005, 11(12): 1295-1298.
|
| 27 |
Mohiuddin MM, Singh AK, Corcoran PC, et al. One-year heterotopic cardiac xenograft survival in a pig to baboon model[J]. Am J Transplant, 2014, 14(2)：488-489.
|
| 28 |
Azimzadeh AM, Kelishadi SS, Ezzelarab MB, et al. Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement pathway-regulatory protein[J]. Xenotransplantation, 2015, 22(4): 310-316.
|
| 29 |
Iwase H, Hara H, Ezzelarab M, et al. Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts[J]. Xenotransplantation, 2017, 24(2): e12293.
|
| 30 |
Reichart B, Längin M, Denner J, et al. Pathways to clinical cardiac xenotransplantation[J]. Transplantation, 2020, 105(9)：1930-1943.
|
| 31 |
Davis EA, Pruitt SK, Greene PS, et al. Inhibition of complement, evoked antibody, and cellular response prevents rejection of pig-to-primate cardiac xenografts[J]. Transplantation, 1996, 62(7): 1018-1023.
|
| 32 |
Kobayashi T, Taniguchi S, Neethling FA, et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy[J]. Transplantation, 1997, 64(9): 1255-1261.
|
| 33 |
Mohiuddin MM, Singh AK, Corcoran PC, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46. hTBM pig-to-primate cardiac xenograft[J]. Nat Commun, 2016, 7: 11138.
|
| 34 |
Mohiuddin MM, Reichart B, Byrne GW, et al. Current status of pig heart xenotransplantation[J]. Int J Surg, 2015, 23(Pt B): 234-239.
|
| 35 |
Dichiacchio L, Singh A, Chan J, et al. Human thrombomodul in expression confers prolonged graft survival over costimulation blockade alone in a pig-to-baboon heterotopic cardiac xenotransplant model[J]. J Heart Lung Transplant, 2018, 37(Suppl 4): S32.
|
| 36 |
Kemter E, Schnieke A, Fischer K, et al. Xeno-organ donor pigs with multiple genetic modifications - the more the better？[J]. Curr Opin Genet Dev, 2020，64: 60-65.
|
| 37 |
Hawthorne WJ, Cowan PJ, Buhler LH, et al. Third WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials, Changsha, Hunan, China December 12-14, 2018: " The 2018 Changsha Communique" The 10-Year Anniversary of The International Consultation on Xenotransplantation[J]. Xenotransplantation, 2019, 26(2): e12513.
|
| 38 |
Platt JL, West LJ, Chinnock RE, et al. Toward a solution for cardiac failure in the newborn[J]. Xenotransplantation，2018，25(6): e12479.
|
| 39 |
Cleveland D, Adam BC, Hara H, et al. The case for cardiac xenotransplantation in neonates: is now the time to reconsider xenotransplantation for hypoplastic left heart syndrome？[J]. Pediatr Cardiol, 2019, 40(2): 437-444.
|
| 40 |
Lam TT, Paniagua R, Shivaram G, et al. Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys[J]. Xenotransplantation, 2004, 11(6): 531-535.
|
| 41 |
Mcgregor CG, Davies WR, Oi K, et al. Cardiac xenotransplantation: recent preclinical progress with 3-month median survival[J]. J Thorac Cardiovasc Surg, 2005, 130(3): 844-851.
|
| 42 |
Längin M, Mayr T, Reichart B, et al. Consistent success in life-supporting porcine cardiac xenotransplantation[J]. Nature, 2018, 564(7736)：430-433.
|
| 43 |
Reichart B, Längin M, Denner J, et al. Pathways to clinical cardiac xenotransplantation[J]. Transplantation, 2020, 105(9)：1930-1943.
|
| 44 |
Bauer A, Postrach J, Thormann M, et al. First experience with heterotopic thoracic pig-to-baboon cardiac xenotransplantation[J]. Xenotransplantation, 2010, 17(3)：243-249.
|
| 45 |
Uli B, Arne S. PASylation (R): a versatile technology to extend drug delivery[J]. Curr Opin Colloid Interface Sci, 2017, 31: 10-17.
|
| 46 |
Cooper DK, Keogh AM, Brink J, et al. Report of the xenotransplantation advisory committee of the international society for heart and lung transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases[J]. J Heart Lung Transplant, 2000, 19(12): 1125-1165.
|
| 47 |
Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1，3-galactosyltransferase gene-knockout pigs as donors: initial experience[J]. Nat Med, 2005, 11(1): 29-31.
|
| 48 |
Imamura T, Kinugawa K, Nitta D, et al. Everolimus attenuates myocardial hypertrophy and improves diastolic function in heart transplant recipients[J]. Int Heart J, 2016, 57(2): 204-210.
|
| 49 |
Rao JS, Matson AW, Taylor RT, et al. Xenotransplantation literature update January/February 2021[J]. Xenotransplantation, 2021, 28(3): e12685.
|
| 50 |
Porrett PM, Orandi BJ, Kumar V, et al. First clinical-grade porcine kidney xenotransplant using a human decedent model[J]. Am J Transplant, 2022, 22(4)：1037-1053.
|
| 51 |
Byrne GW, Davies WR, Oi K, et al. Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival[J]. Transplantation, 2006, 82(12): 1787-1791.
|
| 52 |
Cooper DKC, Iwase H, Yamamoto T, et al. Life-supporting porcine cardiac xenotransplantation: the munich study[J]. Xenotransplantation, 2019, 26(3): e12486.
|
| 53 |
Maeda A, Lo PC, Sakai R, et al. A strategy for suppressing macrophage-mediated rejection in xenotransplantation[J]. Transplantation, 2020, 104(4)：675-681.
|
| 54 |
Denner J. Reduction of the survival time of pig xenotransplants by porcine cytomegalovirus[J]. Virol J, 2018, 15(1)：171.
|
| 55 |
Denner J, Scobie L, Schuurman H. Is it currently possible to evaluate the risk posed by PERVs for clinical xenotransplantation？[J]. Xenotransplantation, 2018, 25(4): e12403.
|
| 56 |
Goerlich CE, Chan JL, Mohiuddin MM. Regulatory barriers to xenotransplantation[J]. Curr Opin Organ Transplant, 2019, 24(5)：522-526.
|
| 57 |
Yamada K, Tasaki M, Sekijima M, et al. Porcine cytomegalovirus infection is associated with early rejection of kidney grafts in a pig to baboon xenotransplantation model[J]. Transplantation, 2014, 98(4)：411-418.
|
| 58 |
Niu D, Wei HJ, Lin L, et al. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9[J]. Science, 2017, 357(6357): 1303-1307.
|
| 59 |
Uwe F, Jan-Michael A, Tanja M, et al. Distribution of porcine cytomegalovirus in infected donor pigs and in baboon recipients of pig heart transplantation[J]. Viruses, 2018, 10(2): 66.
|
| 60 |
Domenech N, Sanchez-Corral P. Xenoantibodies and complement activity determinations by flow cytometry in pig-to-primate xenotransplantation[J]. Methods Mol Biol, 2020, 2110: 73-81.
|
| 61 |
Bauer A, Postrach J, Thormann M, et al. First experience with heterotopic thoracic pig-to-baboon cardiac xenotransplantation[J]. Xenotransplantation, 2010，17(3)：243-249.
|